logo
logo

Endo Acquires Six Development-Stage, Ready-To-Use Injectable Product Candidates From Nevakar

Endo Acquires Six Development-Stage, Ready-To-Use Injectable Product Candidates From Nevakar

05/02/22, 11:56 AM
Industry
real estate
software
Endo International plc (NASDAQ: ENDP) announced today that its subsidiary Endo Ventures Limited (EVL) acquired six development-stage, ready-to-use injectable product candidates from Nevakar Injectables Inc., a subsidiary of Nevakar, Inc.

Company Info

Company
Endo
Company info
Endo (NASDAQ: ENDP) is a specialty pharmaceutical company committed to helping everyone we serve live their best life through the delivery of quality, life-enhancing therapies. Our decades of proven success come from passionate team members around the globe collaborating to bring the best treatments forward. Together, we boldly transform insights into treatments benefiting those who need them, when they need them. Learn more at www.endo.com or connect with us on LinkedIn.